460 results on '"Janot, F"'
Search Results
2. Reconstruction of maxillectomy and midfacial defects using latissimus dorsi-scapular free flaps in a comprehensive cancer center
3. Chirurgia dei tumori sinusali
4. Sentinel node biopsy in early oral squamous cell carcinomas: Long-term follow-up and nodal failure analysis
5. Cirugía de los tumores sinusales
6. Melanomi mucosi cervicofacciali
7. Épidémiologie, facteurs de risque, prévention des cancers du larynx
8. Development of minimally invasive surgery for sinonasal malignancy
9. Développement de la chirurgie minimale invasive dans la prise en charge des cancers naso-sinusiens
10. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases
11. Les carcinomes adénoïdes kystiques ORL : une étude multicentrique prospective REFCOR de 95 cas
12. Laringectomia totale e faringolaringectomia totale
13. Laringectomía total y faringolaringectomía total
14. Résultats de la radiothérapie dans les carcinomes épidermoïdes du larynx avec atteinte sous-glottique
15. 909P Immunoscore-IC predicts nivolumab efficacy as adjuvant treatment after salvage surgery in head and neck cancer squamous cell carcinoma: The ADJORL1 trial
16. Volumes cibles en radiothérapie des adénopathies cervicales de primitif inconnu : état des lieux et pistes vers une approche sélective raisonnée sous l’égide du Refcor (Réseau d’expertise français des cancers ORL rares)
17. Multimodal treatment and long-term outcome of patients with esthesioneuroblastoma
18. Paraneoplastic dermatomyositis accompanying nasopharyngeal carcinoma: Diagnosis, treatment and prognosis
19. Dermatomyosite paranéoplasique et carcinome nasopharyngé : diagnostic, traitement et pronostic
20. Thymidylate synthase activity and Folate levels in head and neck squamous cell carcinomas
21. Squamous cell carcinoma of the larynx with subglottic extension: is larynx preservation possible?
22. Prise en charge des cancers ORL rares : synthèse des recommandations du réseau d’expertise français REFCOR
23. Replacement of lip-split mandibulotomy by pull-through approach for T3–4 oral carcinomas
24. Place du curage ganglionnaire après chimioradiothérapie dans les carcinomes épidermoïdes des voies aérodigestives supérieures avec atteinte ganglionnaire initiale (nasopharynx exclu)
25. 855MO Adjuvant immunotherapy after salvage surgery in head and neck cancer squamous cell carcinoma (HNSCC): Phase II trial evaluating the efficacy and the toxicity of Nivolumab (ADJORL1)
26. Early locoregional high-dose radiotherapy is associated with long-term disease control in localized primary angiocentric lymphoma of the nose and nasopharynx
27. Hyperselective intra-arterial preoperative chemotherapy in patients with squamous cell carcinoma of the oral cavity: preliminary results
28. Primary clear cell sarcoma of the tongue and surgical reconstruction: About a rare case report
29. Locally advanced nasal pyramid squamous cell carcinoma: our 15 years’ experience in a series of 35 total rhinectomies
30. Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol
31. Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France
32. Molecular analysis of oesopharyngeal brush samples for early detection of head and neck squamous cell carcinomas: O101
33. Les carcinomes épidermoïdes du voile du palais : le problème des deuxièmes cancers : à propos des 98 cas traités à l’Institut Gustave-Roussy de 1986 à 1992
34. The anterolateral thigh perforator flap in pharyngo-esophageal reconstruction
35. SYM6 Microvascular Free Tissue Transfer in Pediatric Craniofacial Reconstruction
36. OC-0586 Immunological contexture basis of a prognostic radiomics signature in head and neck cancers
37. AcSé immunotherapy trials: Anti-PD-1 therapy for adult patients with selected rare cancer types
38. Long-term response in patient with recurrent oropharyngeal carcinoma treated with cetuximab, docetaxel and cisplatin (TPEx) as first-line treatment followed by cetuximab maintenance
39. EP-1158: Prognostic factors and role of neck dissection in N3 head and neck cancers treated with radiotherapy
40. OC-0272: Twice daily reirradiation with cetuximab vs once daily chemoRT after surgery in head and neck cancer
41. OC-0489: TAM and HLA class I expression in relation to HPV and clinical outcome in head and neck cancer
42. Melanomas mucosos cervicofaciales
43. What is the most effective treatment for head and neck squamous cell carcinoma? : An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups
44. Oral cavity cancers among young people: clinical results and prognostic analysis Cancers de la cavité buccale chez les sujets jeunes: Résultats thérapeutiques et analyse de facteurs pronostiques
45. Head and neck adenoid cystic carcinoma: A prospective multicenter REFCOR study of 95 cases
46. Clinical Relevance of Tumor Infiltrating Lymphocytes, PD-L1 Expression, and Correlation with HPV/P16 in Head and Neck Cancer Treated with Bio- or Chemoradiation Therapy
47. Chemoradiotherapy versus radiotherapy in the treatment of salivary glands and nasal tumors: The GORTEC 2016-02 study
48. OC-0400: Prognostic impact of tumor infiltrating lymphocytes and PD-L1 expression in head and neck cancers
49. PO-0966: Prognostic value of tissue necrosis, CD34 MVD and CA-IX in head and neck cancer patients
50. What is the most effective treatment for head and neck squamous cell carcinoma? An individual patient data network meta-analysis from the MACH-NC and MARCH collaborative groups
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.